.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

POLYETHYLENE GLYCOL 3350 Drug Profile

« Back to Dashboard
Polyethylene Glycol 3350 is a drug marketed by Nuvo Pharm Inc, Nexgen Pharma Inc, Nexgen Pharma, Par Pharm, Mylan, Strides Pharma, Breckenridge Pharm, Teva Pharms, Ani Pharms Inc, Paddock Llc, Raritan Pharms Inc, Novel Labs Inc, and Perrigo R And D. and is included in fifteen NDAs. It is available from sixty-two suppliers.

The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and fourteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

Summary for Tradename: POLYETHYLENE GLYCOL 3350

Patents:0
Applicants:13
NDAs:15
Suppliers / Packagers: see list62
Drug Prices: :see details

Pharmacology for Tradename: POLYETHYLENE GLYCOL 3350

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharm Inc
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL206105-001Oct 28, 2016OTCNo► subscribe► subscribe
Paddock Llc
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
FOR SOLUTION;ORAL090712-001Feb 25, 2010DISCNNo► subscribe► subscribe
Strides Pharma
POLYETHYLENE GLYCOL 3350
polyethylene glycol 3350
FOR SOLUTION;ORAL203928-001Aug 24, 2016OTCNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc